Dokuz Eylul University
Izmir, Turkey (Türkiye)
NCT Number: NCT05066880
In recent years, there is growing interest in illustrating the health benefits of exercise among epilepsy. Although exercise is recommended for patients with epilepsy, there is uncertainty concerning the effects of yoga and aerobic exercise on multiple health outcomes in epilepsy. The aim of this trial is to examine the effects of yoga and aerobic exercise training on physical activity, health-related physical fitness, mental, emotional, and psychological health status, seizure frequency and quality of life.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Izmir, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Exercise training for 8 weeks
Time frame: change from baseline to 8 weeks
Physical activity will be objectively monitored with an accelerometer.
Time frame: change from baseline to 8 weeks
Participants will be given a seizure diary and requested to record the number of their seizure.
Time frame: change from baseline to 8 weeks
The Six-Minute Walk test will be used to determine functional capacity.
Time frame: change from baseline to 8 weeks
Lower body strength will be determined using the 30-second Chair Stand test.
Time frame: change from baseline to 8 weeks
Balance evaluation will be performed with Biodex Balance System.
Time frame: change from baseline to 8 weeks
Body composition measurements will be performed with bioelectrical impedance analyzer.
Time frame: change from baseline to 8 weeks
For the anthropometric measurements, waist and hip circumference will be taken.
Time frame: change from baseline to 8 weeks
The Trail Making test and Digit Span test will be used to evaluate for attention.
Time frame: change from baseline to 8 weeks
The Stroop test and Verbal Fluency will be used to evaluate for executive functions.
Time frame: change from baseline to 8 weeks
The Weschler Memory Scale-Revised Visual Reproduction subtest will be used to evaluate for visual memory.
Time frame: change from baseline to 8 weeks
The Clock Drawing test will be used to evaluate for visual perception and visual-spatial functions.
Time frame: change from baseline to 8 weeks
The Oktem Verbal Memory Processes test will be used to evaluate for verbal memory performance.
Time frame: change from baseline to 8 weeks
The Neurological Disorders Depression Inventory for Epilepsy will be used to evaluate for depression.
Time frame: change from baseline to 8 weeks
Anxiety will be determined by the Generalized Anxiety Disorder-7.
Time frame: change from baseline to 8 weeks
The 10-item Perceived Stress Scale will be used to assess subjective stress.
Time frame: change from baseline to 8 weeks
Fatigue will be assessed with the Fatigue Impact Scale.
Time frame: change from baseline to 8 weeks
Sleep quality will be measured using the Pittsburg Sleep Quality Index.
Time frame: change from baseline to 8 weeks
It will be used to determine health-related quality of life for epilepsy.
Dokuz Eylul University
Other
Investigation of the Effects of Yoga and Aerobic Exercise Training on Physical and Mental Health in People With Epilepsy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07373431
Autism Spectrum Disorder, Behavior
Lund, Sweden
View Trial DetailsNCT05359003
Behavior, Brain Diseases
Winston-Salem, North Carolina, United States
View Trial DetailsNCT04357912
Behavior, Brain Diseases
Houston, Texas, United States
View Trial DetailsNCT04311151
Behavior, Brain Diseases
View Trial Details